Spotlight Stage: Finding the Few: Inside Pharming’s and Valeris’ Mission to Identify Undiagnosed APDS Patients

Session details:

A few years ago, Pharming and Valeris set out to increase awareness of APDS--Activated PI3K Delta Syndrome, an ultrarare inherited condition that impairs the immune system--among physicians who, the data hinted, had a higher likelihood of having an APDS patient. The goal? To give reps the insights they needed to make inroads with this hard-to-reach group. In this fireside chat, Pharming and Valeris leaders detail the data-centric but deeply human collaboration that ultimately prompted physicians to conduct more genetic testing of appropriate patients... and reshaped a new market along the way.